Daniel S. Lorrain
Chief Scientific Officer · Contineum Therapeutics, Inc.
- 2024
- Jul 10, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel S. Lorrain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Carmine N. Stengone - $401K in CTNM purchases and sales in the last 12 months
- Tim Watkins - $279K in CTNM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel S. Lorrain?
Daniel S. Lorrain is a corporate insider, tracked as Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Daniel S. Lorrain last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 13 filings going back to 2024.
Has Daniel S. Lorrain been buying or selling stock?
Recorded transactions: 0 open-market purchases and 19 open-market sales ($1.16M) across all tracked filings.
